1. Sensitivity of hiPSC-derived neural stem cells (NSC) to Pyrroloquinoline quinone depends on their developmental stage
- Author
-
Pawel Gaj, Piotr P. Stepien, Leonora Buzanska, Marzena Zychowicz, Monika Kolanowska, Jacek Lenart, G. Lipka, and Justyna Augustyniak
- Subjects
0301 basic medicine ,Cellular differentiation ,Induced Pluripotent Stem Cells ,SDHA ,Gene Dosage ,PQQ Cofactor ,Cell Count ,Biology ,Toxicology ,Antioxidants ,Mitochondrial Proteins ,03 medical and health sciences ,chemistry.chemical_compound ,Pyrroloquinoline quinone ,Neural Stem Cells ,Glial Fibrillary Acidic Protein ,Humans ,NRF1 ,Progenitor cell ,Membrane Potential, Mitochondrial ,Nuclear Respiratory Factor 1 ,Cell Differentiation ,General Medicine ,TFAM ,Molecular biology ,Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha ,Neural stem cell ,Mitochondria ,DNA-Binding Proteins ,030104 developmental biology ,Mitochondrial biogenesis ,chemistry ,Reactive Oxygen Species ,Microtubule-Associated Proteins ,Transcription Factors - Abstract
Pyrroloquinoline quinone (PQQ) is a factor influencing on the mitochondrial biogenesis. In this study the PQQ effect on viability, total cell number, antioxidant capacity, mitochondrial biogenesis and differentiation potential was investigated in human induced Pluripotent Stem Cells (iPSC) - derived: neural stem cells (NSC), early neural progenitors (eNP) and neural progenitors (NP). Here we demonstrated that sensitivity to PQQ is dependent upon its dose and neural stage of development. Induction of the mitochondrial biogenesis by PQQ at three stages of neural differentiation was evaluated at mtDNA, mRNA and protein level. Changes in NRF1, TFAM and PPARGC1A gene expression were observed at all developmental stages, but only at eNP were correlated with the statistically significant increase in the mtDNA copy numbers and enhancement of SDHA, COX-1 protein level. Thus, the "developmental window" of eNP for PQQ-evoked mitochondrial biogenesis is proposed. This effect was independent of high antioxidant capacity of PQQ, which was confirmed in all tested cell populations, regardless of the stage of hiPSC neural differentiation. Furthermore, a strong induction of GFAP, with down regulation of MAP2 gene expression upon PQQ treatment was observed. This indicates a possibility of shifting the balance of cell differentiation in the favor of astroglia, but more research is needed at this point.
- Published
- 2017